Generic Yaz Birth Control Pill Recall Issued Due To Potential Lack Of Potency
One lot of generic Yaz birth control pills are being recalled due to potential potency issues, which could result in unwanted pregnancies.
Tag Archives: Yaz
-
-
Generic Yasmin Recall Issued Due to Pregnancy Risk From Incorrect Packaging of Birth Control Pills
Apotex Corp. is recalling four lots of generic Yasmin birth control pills which may have missing or improperly arranged pills in the blister packs.
-
Mirena IUD Complications Reported to FDA Outnumber All Other Contraceptives: ISMP Report
A new report by the ISMP shows that the MIrena IUD is associated with more serious adverse health problems than four of the other most popular forms of contraception combined.
-
Yaz, Yasmin Settlements Continue to Move Forward in MDL
More than four years after the first Yaz and Yasmin settlements were reported, Bayer continues to reach deals to resolve hundreds of additional cases over their controversial birth control pill.
-
Yaz Stroke, Heart Attack Settlement to Result in Payment of Another $56.9M
Bayer will pay $56.9 million to resolve lawsuits by women who say they suffered a stroke or heart attack while taking Yaz or Yasmin birth control pills.
-
Bayer Still Faces 4,000 Yaz and Yasmin Lawsuits, Even After $2B in Settlements
Even after settling nearly 10,000 Yaz and Yasmin lawsuits, Bayer still faces about 4,000 claims by women who said they suffered injuries due to the birth control pills' side effects.
-
Newer Birth Control Pills Increase Risk of Blood Clot-Related Injuries: Study
U.K. researchers say that newer progestin-based birth control pills carry a significantly increased risk of blood clots when compared to older formulations.
-
Yasmin, Yaz Lawsuits to be Remanded by MDL Judge Following June Trial
The judge presiding over all Yaz and Yasmin lawsuits indicates that he will begin sending cases to courts throughout the country for individual trials.
-
Report Reveals Some FDA Advisors Have Undisclosed Financial Ties
A new report raises concerns that the FDA is revealing only a fraction of the potential conflicts of interest on its advisory boards.
-
Judge Orders 33 Yasmin, Yaz Lawsuits Be Prepared for Trials Nationwide
A group of 33 remaining Yaz and Yasmin lawsuits have been selected to be prepared for trials that may begin by May 2015, after Bayer continues to refuse to settle…
